Clinical Advisor2h
FDA Delays Final Approval of Novavax COVID Vaccine
The decision had been expected by April 1, but the agency now says it needs more information before moving forward.
Dramatic HHS cuts leave US ‘weaker as a nation,’ says top FDA vaccine official forced out under Kennedy
Sweeping job cuts and reorganizations taking place at the US Department of Health and Human Services under Secretary Robert F ...
Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March
Shares of early-stage biotech stocks, including Biohaven ( BHVN -6.50%), Recursion Pharmaceuticals ( RXRX -7.37%), and CRISPR ...
Here's How Trump's Pick To Lead The FDA Can Supercharge The Agency
The U.S. Senate last week confirmed former Johns Hopkins surgeon and professor Dr. Marty Makary to lead the Food and Drug ...
FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearance
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
Medical Device Network on MSN3d
‘Fear and uncertainty’ linger over FDA’s future in wake of Trump admin’s layoffs
This week, the Trump administration followed through on its planned mass layoffs at agencies under the US Department of ...
Fierce Pharma3d
Amid FDA tumult, agency misses decision deadline on Novavax's COVID shot
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
Healthline3d
FDA Authorizes First At-Home Test for Chlamydia, Gonorrhea: What to Know
The FDA has approved a new at-home test for common sexually transmitted infections and diseases. The test for chlamydia, ...
Durham biotech's stock price drops 30% amid offering, reports about product safety
A Durham biotechnology company has seen its stock price plummet over the past few days amid a stock offering and a media ...